Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Investigating the Noradrenergic System in the Living Human Brain With Hybrid Molecular Functional Imaging

Authors not listed

Hospices Civils de Lyon · 2019

Abstract

The main goal of this research proposal is to provide, for the first time in humans, a wider understanding of the role of the noradrenergic system both in health and illness (Parkinson's disease) through the use of a newly developed radiotracer (11Carbon \[11C\]Yohimbine) visualizing alpha-2 (α2) adrenergic receptors (AR) combined with cutting-edge technology, the hybrid positron emission tomography (PET)/magnetic resonance imaging (MRI) scanner. The secondary aim of this study will be to determine whether the expected age- and Parkinson's disease (PD)-related changes in the noradrenergic system are paralleled by changes in neuropsychological performances (such as cognitive, motor and/or olfactory abilities).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-24 MST

Cite this

APA
Anonymous. (2019). Investigating the Noradrenergic System in the Living Human Brain With Hybrid Molecular Functional Imaging. <em>Hospices Civils de Lyon</em>. https://clinicaltrials.gov/study/NCT03942289
Vancouver
Anonymous. Investigating the Noradrenergic System in the Living Human Brain With Hybrid Molecular Functional Imaging. Hospices Civils de Lyon. 2019.
BibTeX
@misc{anon2019Invest, title = {Investigating the Noradrenergic System in the Living Human Brain With Hybrid Molecular Functional Imaging}, author = {Anonymous}, journal = {Hospices Civils de Lyon}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings